A new topical antibiotic formulation, designed to overcome drug resistance of MRSA, is now available OTC. Known as Tetracycline-ABC, it kills the most drug-resistant and the most deadly bacteria (Staph, MRSA and Acinetobacter), which cause community or hospital acquired infections.